VeilPoint Corp. · Partners and investors

Care is moving home. The record is not following it.

VeilPoint Corp. is building the connected record for prescribed treatment at home: an app for the patient, a workspace for the clinic and, in development, devices for the injection itself. This page is an overview for investors, clinical advisors, clinics and strategic partners.

Request the briefing How the system fits together
The CliniTrack dashboard, the Track+ app on a phone and the AutoIM device shown together

Who this is for

Investors

A software business that launches first, with a clinic product and devices that build on the same patient record.

Clinical advisors

Help shape how treatment at home is recorded, shared with consent and reviewed between visits.

Clinics and care teams

See what your patients are doing between visits, with their approval, starting with the CliniTrack beta.

Explore CliniTrack

Strategic partners

Pharmacy, telehealth, engineering, manufacturing and data partners whose patients manage treatment at home.

The gap we are closing

Treatment leaves the clinic. Visibility stops at the door.

The patient is on their own

Injections and multi-medication routines are prescribed in the clinic and carried out at home, without supervision.

The record is scattered

Doses, injection sites, vials, symptoms and lab results end up in memory, notes apps and paper.

The clinic finds out late

Care teams learn what happened at the next visit, from whatever the patient remembers.

The system

Three layers on one patient record.

Each layer adds to the one before it. The patient app launches first, the clinic workspace joins the same record, and the devices are designed to connect the injection itself.

Layer 1 · The patient

Track+

A patient-owned record of treatment at home: injections, medications, supplies, symptoms and labs.

Planned launch: Q1 2027, iOS and Android

Layer 2 · The clinic

CliniTrack

A care-team workspace that turns patient-approved data into review queues and follow-up.

Planned beta: Q1 2027. Full release and API: Q3 2027

Layer 3 · The injection

AutoIM and AutoSQ

Reusable, touchscreen-guided injection aids designed around standard prescription syringes.

In development. Patent pending

Sharing runs on the patient's consent

  1. 1. PairPatient and clinic exchange one-time codes.
  2. 2. ShareThe patient chooses what to share and can pause at any time.
  3. 3. RespondDose changes, lab requests and messages go back.
  4. 4. ProgressEach visit starts from a clear record of what happened.

The data, in broad strokes

A record the patient owns and chooses to share.

What it holds

Injection and medication history, medication supplies and lot numbers, symptoms and instances, lab results, body composition, and wearable and journal entries, all time-stamped in one place.

Who controls it

The patient. The record stays with them between clinics. Sharing is opt-in for each clinic, can be paused or ended at any time, and every access is logged.

How it is used

To run the patient's routine and, with consent, to support clinic follow-up. We do not sell personal health information or use it for targeted advertising.

Market signals

More treatment is happening at home every year.

64.8%

of U.S. adults took a prescription medication in the past year.

CDC, 2021

11%

of U.S. adults take a GLP-1 for weight loss, up from 3% in 2024.

Gallup, 2026

11M+

U.S. testosterone prescriptions in 2024, up from about 7.3 million in 2019.

SingleCare analysis

435,426

assisted reproduction cycles at 457 U.S. clinics in 2022.

CDC, 2022

~76,000

primary care businesses in the United States.

IBISWorld, 2025

Public figures from the sources named. VeilPoint's own market sizing is part of the briefing.

VeilPoint Corp. logo

Our mission

Make prescribed care at home easier to perform, easier to understand, and easier for a care team to oversee.

Where we stand

Early, and clear about it.

We describe each product as it is today. Dates are targets, and nothing here is a performance claim.

Meet the team
Company
VeilPoint Corp. is incorporated, veteran-founded and based in Charlotte, North Carolina.
Track+
Planned to launch on iOS and Android in Q1 2027.
CliniTrack
A working simulator on synthetic data today. Beta with select clinics planned for Q1 2027; full release and the Track+ API planned for Q3 2027.
Devices
AutoIM and AutoSQ are in development and are not available for sale.
Intellectual property
Patent pending. A U.S. provisional patent application was filed on July 14, 2026.

Go deeper

Request the investor and partner briefing

Tell us who you are and what you would like to see. Detailed material is shared after a conversation with our team.

  1. Send your request. We reply by email.
  2. Talk with us. A short conversation about what you are looking for.
  3. Receive the briefing. Shared under a non-disclosure agreement.
I am reaching out as

We use these details only to respond to your request.